Indiana University


NIH funding puts researchers on path to restoring vision loss from diabetic eye disease

March 12, 2013 -- Researchers at the Eugene and Marilyn Glick Eye Institute and the Indiana Center for Vascular Biology at Indiana University School of Medicine are on the cusp of perfecting stem cell treatments that would halt – and potentially reverse – vision loss caused by diabetic retinopathy.

Inhibition of enzyme could lead to improved chemotherapy and stem cell transplant results

November 21, 2012 -- Blocking the action of one enzyme could mean improved results for thousands of cancer patients who undergo bone marrow or cord blood transplants after chemotherapy, an Indiana University research team has reported.

Glick Eye Institute physicians and researchers receive grants to aid vision discoveries

June 18, 2012 -- Three researchers at the Eugene and Marilyn Glick Eye Institute have received funding for glaucoma and diabetic retinopathy research, including a grant for more than $1 million from the National Eye Institute.

Indiana University Researchers Take Steps Toward Prevention of Diabetes

March 22, 2012 -- Early signals that insulin processing cells are developing problems that result in type 1 diabetes may lead to tests to predict who will develop the disease and possibly how to prevent it, according to Indiana University School of Medicine researchers.

Pilot Diabetes Program Links Doctors, Patients and Communities to Health Resources

February 29, 2012 -- A pilot program at the Indiana University School of Medicine Diabetes Translational Research Center hopes to streamline the process of connecting people with type 2 diabetes to community wellness resources.